Skip to main content
SpringerLink
Log in

The Skin, Selected Dermatologic Conditions, and Medical Nutrition Therapy

  • Chapter
  • First Online:
Integrative and Functional Medical Nutrition Therapy

  • 2571 Accesses

Abstract

The skin is the interfacing barrier to the external environment. Its integrity is required for protection and health. The cells are continuously being replaced in response to both intrinsic and extrinsic forces. Diet and lifestyle affect the skin health. Genetic makeup, including microRNA, also impacts the degree of skin disease. The incorporation of adequate protein, essential fatty acids, low-glycemic carbohydrates, fermented foods, water, minerals, vitamins, and phytonutrient-rich vegetables modulate the endocrine and immunologic systems of the skin, providing the best opportunity for health. Nutritional requirements for this organ system vary widely depending on its state of health or condition. Common skin ailments are impacted by medical nutrition therapies that can alter the severity of the condition. The application of food and dietary choices, the modified elimination diet, and nutrient or bioactive supplementation may impact the root causes of the skin condition. Dermatologic conditions are common in clinical practice. Common conditions may be a result of underlying metabolic dysfunction (acanthosis nigricans); immunologic epigenetic perturbations (psoriasis and pemphigus); the gut-brain-skin axis dysfunction (acne vulgaris and acne rosacea); genetic or acquired deficiency (zinc and acrodermatitis enteropathica, follicular hyperkeratosis); food-triggered hypersensitivity (dermatitis herpetiformis); a multifactorial imbalance of genetic, environmental, innate, and acquired immune dysfunction (atopic dermatitis); and frank deficiency (pellagra, scurvy). These conditions may respond to targeted medical nutrition therapy. The therapeutic opportunities for each common condition are reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Landis ET, Scott A, Davis SA, Feldman SR, Taylor S. The complementary and alternative medicine use in dermatology in the United States. J Altern Complement Med. 2014;20(5):392–8.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Watson RR, Zibadi S, editors. Bioactive dietary factors and plant extracts in dermatology. Nutrition and health. New York: Springer Science+Business Media, Humana Press; 2013.

    Google Scholar 

  3. Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier. Exp Dermatol. 2008;17:1063–72.

    Article  PubMed  Google Scholar 

  4. Tobin DJ. Biochemistry of human skin—our brain on the outside. Chem Soc Rev. 2006;35(1):52–67.

    Article  CAS  PubMed  Google Scholar 

  5. Khnykin D, Miner JH, Jahnsen F. Role of fatty acid transporters in epidermis: implications for health and disease. Dermatoendocrinol. 2011;3(2):53–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Feingold KR. Thematic review series: skin lipids. The role of epidermal lipids in cutaneous permeability barrier homeostasis. J Lipid Res. 2007;48:2531–46.

    Article  CAS  PubMed  Google Scholar 

  7. Man MQ, Feingold KR, Thornfeldt CR, Elias PM. Optimization of physiological lipid mixtures for barrier repair. J Invest Dermatol. 1996;106:1096–101.

    Article  Google Scholar 

  8. Schurer NY, Stremmel W, Grundmann JU, Schliep V, Kleinert H, Bass NM, Williams ML. Evidence for a novel keratinocyte fatty acid uptake mechanism with preference for linoleic acid: comparison of oleic and linoleic acid uptake by cultured human keratinocytes, fibroblasts and a human hepatoma cell line. Biochim Biophys Acta. 1994;1211:51–60.

    Article  CAS  PubMed  Google Scholar 

  9. Uchida Y, Holleran WM. Omega-O-acylceramide, a lipid essential for mammalian survival. J Dermatol Sci. 2008;51:77–87.

    Article  CAS  PubMed  Google Scholar 

  10. Ziboh VA. The significance of polyunsaturated fatty acids in cutaneous biology. Lipids. 1996;31:S249–53.

    Article  CAS  PubMed  Google Scholar 

  11. Ziboh VA, Miller CC, Cho Y. Metabolism of polyunsaturated fatty acids by skin epidermal enzymes: generation of antiinflammatory and antiproliferative metabolites. Am J Clin Nutr. 2000;71:361–6.

    Article  Google Scholar 

  12. McCusker MM, Grant-Kels JM. Healing fats of the skin: the structural and immunologic roles of the omega-6 and omega-3 fatty acids. Clin Dermatol. 2010;28:440–51.

    Article  PubMed  Google Scholar 

  13. Sala-Vila A, Miles EA, Calder PC. Fatty acid composition abnormalities in atopic disease: evidence explored and role in the disease process examined. Clin Exp Allergy. 2008;38:1432–50.

    Article  CAS  PubMed  Google Scholar 

  14. Hachem JP, Crumrine D, Fluhr J, Brown BE, Feingold KR, Elias PM. pH directly regulates epidermal permeability barrier homeostasis and stratum corneum integrity/cohesion. J Invest Dermatol. 2003;121:345–53.

    Article  CAS  PubMed  Google Scholar 

  15. Bouwsta JA, Gooris GS, Dubbelaar FE, Ponec M. Phase behaviour of skin barrier model membranes at pH 7.4. Cell Mol Biol (Noisy-le-Grand). 2000;46:979–92.

    CAS  Google Scholar 

  16. Fluhr JW, Kao J, Jain M, Ahn SK, Feingold KR, Elias PM. Generation of free fatty acids from phospholipids regulates stratum corneum acidification and integrity. J Invest Dermatol. 2001;117:44–51.

    Article  CAS  PubMed  Google Scholar 

  17. Thomas P. Habif. In: Clinical dermatology. 5th ed. Philadelphia: Mosby Elsevier; 2010.

    Google Scholar 

  18. McCully M, Ladell K, Hakobyan S, Mansel RE, Price DA, Moser B. Epidermis instructs skin homing receptor expression in human T cells. Blood. 2012;120(23):4591–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Morizane D, Yamasaki K, Kabigting ED, Gallo RL. Kallikrein expression and cathelicidin processing are independently controlled in keratinocytes by calcium, vitamin D3, and retinoic acid. J Invest Dermatol. 2010;130(5):1297–306.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Stone PM, Boham E. Functional nutrition evaluation: the skin. Federal Way Washington: The Institute for Functional Medicine; 2016. www.FxMed.org.

    Google Scholar 

  21. Stone PM. Functional nutrition evaluation: the 8 step mouth exam. Federal Way Washington: The Institute for Functional Medicine; 2014. www.FxMed.org.

    Google Scholar 

  22. Schmuth M, Fritsch PO. Cutaneous changes in nutritional diseases. In: Krutmann J, Humbert P, editors. Nutrition for healthy skin; strategies for clinical and cosmetic practice. Berlin Heidelberg: Springer-Verlag; 2011. p. 3–14.

    Google Scholar 

  23. Heymsfield SB, Williams PJ. Nutritional assessment by clinical and biochemical methods. In: Modern nutrition in health and disease. 7th ed. Philadelphia: Lea and Febiger; 1988.

    Google Scholar 

  24. Sonkoly E. Pivarcsi: advances in microRNAs: implications for immunity and inflammatory diseases. J Cell Mol Med. 2009;13(1):24–38.

    Article  CAS  PubMed  Google Scholar 

  25. Botchkareva N. MicroRNA/mRNA regulatory networks in the control of skin development and regeneration. Cell Cycle. 2012;11(3):468–74.

    Article  CAS  PubMed  Google Scholar 

  26. Notay M, Foolad N, Vaughn AR, Sivamani RK. Probiotics, prebiotics, and synbiotics for the treatment and prevention of adult dermatological diseases. Am J Clin Dermatol. 2017;18:721–32. https://doi.org/10.1007/s40257-017-0300-2.

    Article  PubMed  Google Scholar 

  27. McCubrey JA, Lertpiriyapong K, Steelman LS, Abrams SL, Yang LV, Murata RM, Rosalen PL, Scalisi A, Neri LM, Cocco L, Ratti S, Martelli AM, Laidler P, Dulińska-Litewka D, Rakus D, Gizak A, Lombardi P, Nicoletti F, Candido S, Libra M, Montalto G, Cervello M. Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs. Aging (Albany NY). 2017;9(6):1477–536.

    Article  CAS  Google Scholar 

  28. Vojdani A, Tarach I. Cross-reaction between gliadin and different food and tissue antigens. Food Nutr Sci. 2013;4:20–32.

    CAS  Google Scholar 

  29. Wolff K, Johnson RA, Saavedra AP. Fitzpatrick’s color atlas and synopsis of clinical dermatology. 7th ed. New York: McGraw-Hill Companies; 2013.

    Google Scholar 

  30. DeWitt CA, Buescher LS, Stone SP. Cutaneous manifestations of internal malignant disease: cutaneous paraneoplastic syndromes. Chapter 153: 1880–1900. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K, editors. Fitzpatrick’s: dermatology in general medicine. 8th ed. New York: McGraw Hill; 2012.

    Google Scholar 

  31. Chung VQ, et al. Clinical and pathologic findings of paraneoplastic dermatosis. J Am Acad Dermatol. 2006;54:745.

    Article  PubMed  Google Scholar 

  32. Kalus AA, Chien AJ, Olerud JE. Diabetes mellitus and other endocrine diseases. Chapter 151: 1840–1869. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K, editors. Fitzpatrick’s: dermatology in general medicine. 8th ed. New York: McGraw-Hill; 2012.

    Google Scholar 

  33. Schwartz RA. Acanthosis nigricans. J Am Acad Dermatol. 1994;31:1.

    Article  CAS  PubMed  Google Scholar 

  34. Sherertz EF. Improved acanthosis nigricans with lipodystrophic diabetes during dietary fish oil supplementation. Arch Dermatol. 1988;124:1094–6.

    Article  CAS  PubMed  Google Scholar 

  35. Malisiewicz B, Boehncke S, Lang V, et al. Epidermal insulin resistance as a therapeutic target in acanthosis nigricans? Acta Derm Venereol. 2014;94:607.

    Article  PubMed  Google Scholar 

  36. Berger BJ, Gross PR. Another use for tretinoin-pseudoacanthosis nigricans. Arch Dermatol. 1973;108:133.

    Article  CAS  PubMed  Google Scholar 

  37. Darmstadt GL, Yokel BK, Horn TD. Treatment of acanthosis nigricans with tretinoin. Arch Dermatol. 1991;127:1139.

    Article  CAS  PubMed  Google Scholar 

  38. Gregoriou S, Anyfandakis V, Kontoleon P, et al. Acanthosis nigricans associated with primary hypogonadism: successful treatment with topical calcipotriol. J Dermatolog Treat. 2008;19:373.

    Article  PubMed  Google Scholar 

  39. Pelle M. Rasacea. Chapter 81. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffel DJ, Wolff K, editors. Fitzpatrick’s dermatology in general medicine. 8th ed. New York: McGraw-Hill; 2012. p. 918–25.

    Google Scholar 

  40. Gaby A. Nutritional medicine. 2nd ed. Concord: Fritz Perlberg Publishing; 2017.

    Google Scholar 

  41. Gravina A, Federico A, Ruocco E, Lo Schiavo A, Masarone M, Tuccillo C, Peccerillo F, Miranda A, Romano L, de Sio C, de Sio I, Persico M, Ruocco V, Riegler G, Loguercio C, Romano M. Helicobacter pylori infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea. United European Gastroenterol J. 2015;3(1):17–24.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Egeberg A, Weinstock LB, Thyssen EP, Gislason GH, Thyssen JP. Rosacea and gastrointestinal disorders: a population-based cohort study. Br J Dermatol. 2017;176(1):100–6. https://doi.org/10.1111/bjd.14930. Epub 2016 Oct 31.

    Article  CAS  PubMed  Google Scholar 

  43. Gupta M, Mahajan VK, Mehta KS, Chauhan PS. Zinc therapy in dermatology: a review. Dermatol Res Pract. 2014;2014:709152.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Ogawa Y, Kinoshita M, Shimada S, Kawamura T. Zinc and skin disorders. Nutrients. 2018;10:199. https://doi.org/10.3390/nu10020199.

    Article  CAS  PubMed Central  Google Scholar 

  45. Sharquie KE, Najim RA, Al-Salaman HD. Oral zinc sulfate in the treatment of rosacea: a double-blind placebo-controlled study. Int J Dermatol. 2006;45:857–61.

    Article  CAS  PubMed  Google Scholar 

  46. Bamford JTM, Gessert CE, Haller IV, et al. Randomized, double-blind trial of 220 mg zinc sulfate twice daily in treatment of rosacea. Int J Dermatol. 2012;51:459–62.

    Article  CAS  PubMed  Google Scholar 

  47. Barba A, Rosa B, Angelini G, et al. Pancreatic exocrine function in rosacea. Dermatologica. 1982;165:601–6.

    Article  CAS  PubMed  Google Scholar 

  48. Dreno B, Amblard P, Agache P, et al. Low doses of zinc gluconate for inflammatory acne. Acta Derm Venereol. 1989;69:541–3.

    CAS  PubMed  Google Scholar 

  49. Verma KC, Sainin AS, Dhamija SK. Oral zinc sulfate therapy in acne vulgaris: a double-blind trial. Acta Derm Venereol. 1980;60:337–40.

    CAS  PubMed  Google Scholar 

  50. Blumenthal M, Busse WR, Goldberg A, et al. The complete German Commission E monographs. In: Therapeutic guide to herbal medicines. Austin: The American Botanical Council; 1998.

    Google Scholar 

  51. Tulipan L. Acne rosacea; a vitamin B complex deficiency. Arch Derm Syphilol. 1947;56(5):589–91. https://doi.org/10.1001/archderm.1947.01520110035005.

    Article  CAS  PubMed  Google Scholar 

  52. Manzhalii E, Hornuss D, Stremmel W. Intestinal-borne dermatoses significantly improved by oral application of Escherichia coli Nissle 1917. World J Gastroenterol. 2016;22(23):5415–21. https://doi.org/10.3748/wjg.v22.i23.5415.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Iijima K, Sekine H, Koike T, Imatani A, Ohara S, Shimosegawa T. Long-term effect of Helicobacter pylori eradication on the reversibility of acid secretion in profound hypochlorhydria. Aliment Pharmacol Ther. 2004;19:1181–8. https://doi.org/10.1111/j.1365-2036.2004.01948.x.

    Article  CAS  PubMed  Google Scholar 

  54. Nazzaro-Porro M. Azelaic acid. J Am Acad Dermatol. 1987;17:1033–41.

    Article  CAS  PubMed  Google Scholar 

  55. Nguyen QH, Bui TP. Azelaic acid. Pharmacokinetic and pharmacodynamics properties and its therapeutic role in hyperpigmentary disorders and acne. Int J Dermatol. 1995;34:75–84.

    Article  CAS  PubMed  Google Scholar 

  56. Purdy S, de Berker D. Acne vulgaris. BMJ Clin Evid. 2011;2011. pii: 1714. 2015;6:147–53.

    Google Scholar 

  57. Zaenglein AL, Graber EM, Thiboutot DM. Acne vulgaris and acneiform eruptions. Chapter 80. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffel DJ, Wolff K, editors. Fitzpatrick’s dermatology in general medicine. 8th ed. New York: McGraw-Hill; 2012. p. 897–917.

    Google Scholar 

  58. Bowe WP, Joshi SS, Shalita AR. Diet and acne. J Am Acad Dermatol. 2010;63:124.

    Article  PubMed  Google Scholar 

  59. Bowe WP, Logan AC. Acne vulgaris, probiotics and the gut-brain-skin axis—back to the future? Gut Pathog. 2011;3:1–3.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Kappas A, Anderson K, Conney A, et al. Nutrition-endocrine interactions: induction of reciprocal changes in the delta 4-5 alpha-reduction of testosterone and the cytochrome P-450-dependent oxidation of estradiol by dietary macronutrients in man. Proc Natl Acad Sci U S A. 1983;80:7646–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Berra B, Rizzo AM. Glycemic index, glycemic load: new evidence for a link with acne. J Am Coll Nutr. 2009;28 Suppl:450S–4S.

    Article  PubMed  Google Scholar 

  62. Adebamowo CA, Spiegelman D, Berkey CS, et al. Milk consumption and acne in teenaged boys. J Am Acad Dermatol. 2008;58(5):787–93.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Smith RN, Mann NJ, Braue A, et al. The effect of a high-protein, low glycemic-load diet versus a conventional, high glycemic-load diet on biochemical parameters associated with acne vulgaris: a randomized, investigator-masked, controlled trial. J Am Acad Dermatol. 2007;57:247.

    Article  PubMed  Google Scholar 

  64. Smith RN, Braue A, Varigos GA, et al. The effect of a low-glycemic diet on acne vulgaris and the fatty acid composition of skin surface triglycerides. J Dermatol Sci. 2008;50(1):41–52.

    Article  CAS  PubMed  Google Scholar 

  65. Jarrousse V, Castex-Rizzi N, Khammari A, et al. Zinc salts inhibit in vitro Toll-like receptor 2 surface expression by keratinocytes. Eur J Dermatol. 2007;17(6):492–6.

    CAS  PubMed  Google Scholar 

  66. Thiboutot D. Acne: hormonal concepts and therapy. Clin Dermatol. 2004;22:419.

    Article  PubMed  Google Scholar 

  67. Cappel M, Mauger D, Thiboutot D. Correlation between serum levels of insulin-like growth factor 1, dehydroepiandrosterone sulfate, and dihydrotestosterone and acne lesion counts in adult women. Arch Dermatol. 2005;141:333.

    Article  CAS  PubMed  Google Scholar 

  68. Holmes MD, Pollak MN, Willett WC, Hankinson SE. Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev. 2002;11:852.

    CAS  PubMed  Google Scholar 

  69. Michaelsson G, Edqvist LE. Erythrocyte glutathione peroxidase activity in acne vulgaris and effect of selenium and vitamin E treatment. Acta Derm Venereol. 1984;64:9–14.

    CAS  PubMed  Google Scholar 

  70. Snider B, Dieteman DF. Pyridoxine therapy for premenstrual acne flare. Arch Dermatol. 1974;110:130–1.

    Article  CAS  PubMed  Google Scholar 

  71. Kligman AM, Mills OH Jr, Leyden JJ, et al. Oral vitamin A in acne vulgaris. Int J Dermatol. 1981;20:278–85.

    Article  CAS  PubMed  Google Scholar 

  72. Kligman AM, Leyden JJ, Mills O. Oral Vitamin A (Retinol) in Acne Vulgaris. In: Orfanos CE, Braun-Falco O, Farber EM, Grupper C, Polano MK, Schuppli R. (eds) Retinoids. Berlin, Heidelberg: Springer; 1981.

    Google Scholar 

  73. Shalita AR, Smith JG, Parish LC, et al. Topical nicotinamide compared with clindamycin gel in the treatment of inflammatory acne vulgaris. Int J Dermatol. 1995;34:434–7.

    Article  CAS  PubMed  Google Scholar 

  74. Khodaeiani E, Foulad RF, Amirnia M, et al. Topical 4% nicotinamide vs 1% clindamycin in moderate inflammatory acne vulgaris. Int J Dermatol. 2013;52:999–1004.

    Article  CAS  PubMed  Google Scholar 

  75. Shahmoradi Z, Iraji F, Siadat AH, Ghorbaini A. Comparison of topical 5% nicotinamide gel versus 2% clindamycin gel in the treatment of the mild–moderate acne vulgaris. A double-blinded randomized clinical trial. J Res Med Sci. 2013;18:115–7.

    PubMed  PubMed Central  Google Scholar 

  76. Schulpis KH, Karikas GA, Georgala S, et al. Elevated plasma homocysteine levels in patients on isotretinoin therapy for cystic acne. Int J Dermatol. 2001;40(1):33–6.

    Article  CAS  PubMed  Google Scholar 

  77. Chanson A, Cardinault N, Rock E, et al. Decreased plasma folate concentration in young and elderly healthy subjects after a short-term supplementation with isotretinoin. J Eur Acad Dermatol Venereol. 2008;22(1):94–100.

    CAS  PubMed  Google Scholar 

  78. Georgala S, Schulpis KH, Georgala C, et al. L-carnitine supplementation in patients with cystic acne on isotretinoin therapy. J Eur Acad Dermatol Venereol. 1999;13(2):205–9.

    CAS  PubMed  Google Scholar 

  79. Ayres S, Mihan R. Acne vulgaris: therapy directed at pathophysiologic defects. Cutis. 1981;28:41–2.

    PubMed  Google Scholar 

  80. Lönnerdal B. Dietary factors influencing zinc absorption. J Nutr. 2000;130:1378S.

    Article  PubMed  Google Scholar 

  81. Jen M, Yan AC. Syndromes associated with nutritional deficiency and excess. Clin Dermatol. 2010;28(6):669–85.

    Article  PubMed  Google Scholar 

  82. Jen M, Yan AC. Sin in nutritional, metabolic, and heritable disease: cutaneous changes in nutritional disease. Chapter 130. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffel DJ, Wolff K, editors. Fitzpatrick’s dermatology in general medicine. 8th ed. New York: McGraw-Hill; 2012. p. 1499–525.

    Google Scholar 

  83. Moynahan EJ. Acrodermatitis enteropathica: a lethal inherited human zinc-deficiency disorder. Lancet. 1974;2:399–400.

    Article  CAS  PubMed  Google Scholar 

  84. Gaby A. Acrodermatitis enteropathica. Chapter 170. In: Gaby A, editor. Nutritional medicine. 2nd ed. Concord: Fritz Perlberg Publishing; 2017. p. 712–3.

    Google Scholar 

  85. WHO/CAH Diarrhoea treatment guidelines including new recommendations for the use of ORS and zinc supplementation for clinic-based healthcare workers. UNICEF, MOST, USAID, Geneva, 2005. http://www.who.int/child-adolescent-health/New_Publications/CHILD_HEALTH/WHO_FCH_CAH_03.7.pdf.

  86. Bhutta ZA, Bird SM, Black RE, et al. Therapeutic effects of oral zinc in acute and persistent diarrhea in children in developing countries: pooled analysis of randomized controlled trials. Am J Clin Nutr. 2000;72:1516.

    Article  CAS  PubMed  Google Scholar 

  87. Lukacik M, Thomas RL, Aranda JV. A meta-analysis of the effects of oral zinc in the treatment of acute and persistent diarrhea. Pediatrics. 2008;121:326.

    Article  PubMed  Google Scholar 

  88. Leung WC, Hessel S, Méplan C, Flint J, Oberhauser V, Tourniaire F, Hesketh JE, von Lintig J, Lietz G. Two common single nucleotide polymorphisms in the gene encoding beta-carotene 15,15′-monooxygenase alter beta-carotene metabolism in female volunteers. FASEB J. 2009;23(4):1041–53.

    Article  CAS  PubMed  Google Scholar 

  89. Sausenthaler S, Koletzko S, Schaaf B, et al. Maternal diet during pregnancy in relation to eczema and allergic sensitization in the offspring at 2 y of age. Am J Clin Nutr. 2007;85(2):530–7.

    Article  CAS  PubMed  Google Scholar 

  90. Samsonov MA, Kalinina AA. Effect of diet therapy on the serum immunoglobulin level in chronic eczema. Vopr Pitan. 1982;2:12–5.

    Google Scholar 

  91. Wickens K, Black PN, Stanley TV, et al. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind randomized, placebo-controlled trial. J Allergy Clin Immunol. 2008;122(4):788–94.

    Article  PubMed  Google Scholar 

  92. Abrahamsson TR, Jakobsson T, Bottcher M, et al. Probiotics in prevention of IgE-associated eczema: a double blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2007;119(5):1174–80.

    Article  CAS  PubMed  Google Scholar 

  93. Frankland AW. Deficiency scrotal dermatitis in P.O.W.s. Br Med J. 1948;1(4560):1023–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  94. Koch C, Dolle S, Metzger M, et al. Docosahexaenoic acid (DHA) supplementation in atopic eczema: a randomized double-blind, controlled trial. Br J Dermatol. 2008;158(4):786–92.

    Article  CAS  PubMed  Google Scholar 

  95. David TJ, Wells FE, Sharpe TC, et al. Low serum zinc in children with atopic eczema. Br J Dermatol. 1984;111(5):597–601.

    Article  CAS  PubMed  Google Scholar 

  96. David TJ, Wells FE, Sharp TC, et al. Serum levels of trace metals in children with atopic eczema. Br J Dermatol. 1990;122(4):485–9.

    Article  CAS  PubMed  Google Scholar 

  97. Ronaghy A, Katz SI, Hall RP III. Dermatitis herpetiformis. Chapter 61. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffel DJ, Wolff K, editors. Fitzpatrick’s dermatology in general medicine. 8th ed. New York: McGraw-Hill; 2012. p. 642–9.

    Google Scholar 

  98. Welsh AL, Ede M. Inositol hexanicotinate for improved nicotinic acid therapy. Preliminary report. Int Rec Med. 1961;174:9–15.

    CAS  PubMed  Google Scholar 

  99. Johnson HH Jr, Binkley GW. Nicotinic acid therapy of dermatitis herpetiformis. J Invest Dermatol. 1950;14:233–7.

    Article  CAS  PubMed  Google Scholar 

  100. Maronn M, Allen DM, Esterly NB. Phrynoderma: a manifestation of vitamin A deficiency?...The rest of the story. Pediatr Dermatol. 2005;22(1):60–3.

    Article  PubMed  Google Scholar 

  101. Chia MW, Tay Y, Liu TT. Phrynoderma: a forgotten entity in a developed country. Singapore Med J. 2008;49(6):e160.

    CAS  PubMed  Google Scholar 

  102. Bagchi K, Halder K, Chowdhury SR. The etiology of phrynoderma. Am J Clin Nutr. 1959;7:251–8.

    Article  CAS  PubMed  Google Scholar 

  103. Ghafoorunissa, Vidyasagar R, Krishnaswamy K. Phrynoderma: is it an EFA deficiency disease? Eur J Clin Nutr. 1988;42(1):29–39.

    CAS  PubMed  Google Scholar 

  104. Lehman E, Rapaport HG. Cutaneous manifestations of vitamin A deficiency in children. JAMA. 1940;114:386–93.

    CAS  Google Scholar 

  105. Shrank AB. Phrynoderma Br. Medizinhist J. 1966;1:29–30.

    CAS  Google Scholar 

  106. Ragunatha S, Kumar VJ, Murugesh SB. A clinical study of 125 patients with phrynoderma. Indian J Dermatol. 2011;56(4):389–92. https://doi.org/10.4103/0019-5154.84760.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  107. Ragunatha S, Jagannath Kumar V, Murugesh SB, Ramesh M, Narendra G, Kapoor M. Therapeutic response of vitamin A, vitamin B complex, essential fatty acids (EFA) and vitamin E in the treatment of phrynoderma: a randomized controlled study. J Clin Diagn Res. 2014;8(1):116–8.

    Article  Google Scholar 

  108. Barthelemy H, Couvet B, Cambazard F. Skin and mucosal manifestations in vitamin deficiency. J Am Acad Dermatol. 1986;15:1263–74.

    Article  CAS  PubMed  Google Scholar 

  109. Loewenthal LJA. A new cutaneous manifestation in the syndrome of vitamin A deficiency. Arch Derm Syphilol. 1933;28(5):700–8.

    Article  Google Scholar 

  110. Duncan KO, Geisse JK, Leffell DJ. Epithelial precancerous lesions. Chapter 113. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffel DJ, Wolff K, editors. Fitzpatrick’s dermatology in general medicine. 8th ed. New York: McGraw-Hill; 2012. p. 1261–82.

    Google Scholar 

  111. Black HS, Herd JA, Goldberg LH, et al. Effect of a low-fat diet on the incidence of actinic keratosis. N Engl J Med. 1994;330:1272–5.

    Article  CAS  PubMed  Google Scholar 

  112. Chen AC, Damian DL. Nicotinamide and the skin. Australas J Dermatol. 2014;55:169–75.

    Article  PubMed  Google Scholar 

  113. Chen AC, Martin AJ, Choy B, et al. A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention. N Engl J Med. 2015;373:1618–26.

    Article  CAS  PubMed  Google Scholar 

  114. Drago F, Ciccarese G, Parodi A. Nicotinamide for skin cancer chemoprevention. N Engl J Med. 2016;374:789–90.

    Article  PubMed  Google Scholar 

  115. Surjana D, Halliday GM, Martin AJ, et al. Oral nicotinamide reduces actinic keratosis in phase II double-blinded randomized controlled trials. J Invest Dermatol. 2012;132:1497–500.

    Article  CAS  PubMed  Google Scholar 

  116. Dublin WB, Hazen BM. Relation of keratosis seborrheica and keratosis senilis to vitamin A deficiency. Arch Dermatol Syph. 1948;57:178–83.

    Article  CAS  Google Scholar 

  117. Gaby A. Actinic keratosis. Chapter 171. In: Gaby A, editor. Nutritional medicine. 2nd ed. Concord: Fritz Perlberg Publishing; 2017. p. 713–5.

    Google Scholar 

  118. Moon TE, Levine N, Carmet B, et al. Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind controlled trial. Cancer Epidemiol Biomarkers Prev. 1997;6:949–56.

    CAS  PubMed  Google Scholar 

  119. Kang S, Goldfarb MT, Weiss JS, et al. Assessment of adapalene gel for the treatment of actinic keratoses and lentigines: a randomized trial. J Am Acad Dermatol. 2003;49:83.

    Article  PubMed  Google Scholar 

  120. Weinstock MA, Bingham SF, VATTC Trial Group. High-dose topical tretinoin for reducing multiplicity of actinic keratoses. J Invest Dermatol. 2010;130(Suppl 1):S63.

    Google Scholar 

  121. Han J, Colditz GA, Hunter DJ. Polymorphisms in the MTHFR and VDR genes and skin cancer risk. Carcinogenesis. 2007;28:390–7.

    Article  CAS  PubMed  Google Scholar 

  122. Chen Y, Parvez F, Gamble M, Islam T, Ahmed A, Argos M, Graziano JH, Ahsan H. Arsenic exposure at low-to-moderate levels and skin lesions, arsenic metabolism, neurological functions, and biomarkers for respiratory and cardiovascular diseases: review of recent findings from the Health Effects of Arsenic Longitudinal Study (HEALS) in Bangladesh. Toxicol Appl Pharmacol. 2009;239(2):184–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  123. Mekonian S, Argos M, Chen Y, et al. Intakes of several nutrients are associated with incidence of arsenic-related keratotic skin lesions in Bangladesh. J Nutr. 2012;142:2126–34.

    Google Scholar 

  124. Biswas J, Sinha D, Mukherjee S, Roy S, Siddiqi M, Roy M. Curcumin protects DNA damage in a chronically arsenic-exposed population of West Bengal. Hum Exp Toxicol. 2010;29:513–24.

    Article  CAS  PubMed  Google Scholar 

  125. Carless MA, Kraska T, Lintell N, Neale RE, Green AC, Griffiths LR. Polymorphisms of the VDR gene are associated with presence of solar keratoses on the skin. Br J Dermatol. 2008;159:804–10.

    Article  CAS  PubMed  Google Scholar 

  126. Lu’o’ng K, Nguyen LT. The roles of vitamin D in seborrhoeic keratosis: possible genetic and cellular signalling mechanisms. Int J Cosmet Sci. 2013;35(6):525–31. https://doi.org/10.1111/ics.12080.

    Article  CAS  PubMed  Google Scholar 

  127. Mitsuhashi Y. New aspects on vitamin D3 ointment; treatment of senile warts with topical application of active forms of vitamin D. Clin Calcium. 2004;14:141–4.

    PubMed  Google Scholar 

  128. Mitsuhashi Y, Kawaguchi M, Hozumi Y, Kondo S. Topical vitamin D3 is effective in treating senile warts possibly by inducing apoptosis. J Dermatol. 2005;32:420–3.

    Article  CAS  PubMed  Google Scholar 

  129. Kumar Y, Bhatia A. Immune-mediated disorders of the skin: role of dietary factors and plant extracts? Chapter 2. In: Watson RR, Zibadi S, editors. Bioactive dietary factors and plant extracts in dermatology. New York: Humana Press; 2013. p. 13–25.

    Google Scholar 

  130. Kieffer M, Barnetson RS. Increased gliadin antibodies in dermatitis herpetiformis and pemphigoid. Br J Dermatol. 1983;108(6):673–8.

    Article  CAS  PubMed  Google Scholar 

  131. Honl BA, Elston DM. Autoimmune bullous eruption localized to a breast reconstruction site: response to niacinamide. Cutis. 1998;62:85–6.

    CAS  PubMed  Google Scholar 

  132. Fivenson DP, Breneman DL, Rosen GB, et al. Nicotinamide and tetracycline therapy of bullous pemphigoid. Arch Dermatol. 1994;I30:753–8.

    Article  Google Scholar 

  133. Belenky P, Bogan KL, Brenner C. NAD+ metabolism in health and disease. Trends Biochem Sci. 2006;32(1):12–9.

    Article  CAS  PubMed  Google Scholar 

  134. Prousky JE. Pellagra may be a rare secondary complication of anorexia nervosa: a systematic review of the literature. Altern Med Rev. 2003;8(2):180–5.

    PubMed  Google Scholar 

  135. Delgado-Sanchez L, Godkar D, Niranjan S. Pellagra: rekindling of an old flame. Am J Ther. 2008;15(2):173–5.

    Article  PubMed  Google Scholar 

  136. Oldham MA, Ivkovic A. Pellagrous encephalopathy presenting as alcohol withdrawal delirium: a case series and literature review. Addict Sci Clin Pract. 2012;7:12.

    Article  PubMed  PubMed Central  Google Scholar 

  137. Hegyi J, Schwartz RA, Hegyi V. Pellagra: dermatitis, dementia, and diarrhea. Int J Dermatol. 2004;43(1):1–5.

    Article  PubMed  Google Scholar 

  138. Guyton JR, Bays HE. Safety considerations with niacin therapy. Am J Cardiol. 2007;99(6A):22C–31C.

    Article  CAS  PubMed  Google Scholar 

  139. Stone NJ, Robinson J, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 2014;63:2889–934.

    Google Scholar 

  140. Gaby A. Psoriasis. Chapter 192. In: Gaby A, editor. Nutritional medicine. 2nd ed. Concord: Fritz Perlberg Publishing; 2017. p. 762–71.

    Google Scholar 

  141. Ricketts JR, Rothe MJ, Grant-Kels JM. Nutrition and psoriasis. Clin Dermatol. 2010;28(6):615–26.

    Article  PubMed  Google Scholar 

  142. Lithell H, Bruce A, Gustafsson IB, Höglund NJ, Karlström B, Ljunghall K, Sjölin K, Venge P, Werner I, Vessby B. A fasting and vegetarian diet treatment trial on chronic inflammatory disorders. Acta Derm Venereol. 1983;63(5):397–403.

    CAS  PubMed  Google Scholar 

  143. Osier E, Wang AS, Tollefson MM, et al. Pediatric psoriasis comorbidity screening guidelines. JAMA Dermatol. 2017;153(7):698–704.

    Article  PubMed  PubMed Central  Google Scholar 

  144. Frigo A, Tambalo C, Bambara LM, Biasi D, Marrella M, Milanino R, Moretti U, Velo G, De Sandre G. Zinc sulfate in the treatment of psoriatic arthritis. Recenti Prog Med. 1989;80:577–81.

    CAS  PubMed  Google Scholar 

  145. Clemmensen OJ, Siggaard-Andersen J, Worm AM, Stahl D, Frost F, Bloch I. Psoriatic arthritis treated with oral zinc sulphate. Br J Dermatol. 1980;103(4):411–5.

    Article  CAS  PubMed  Google Scholar 

  146. Perez A, Raab R, Chen TC, Turner A, Holick MF. Safety and efficacy of oral calcitriol (1,25 dihydroxyvitamin D) for the treatment of psoriasis. Br J Dermatol. 1996;134:1070–8.

    Article  CAS  PubMed  Google Scholar 

  147. Alganatish JT, Algahtani F, Alsewairi WM, Al-kenaizan S. Childhood scurvy: an unusual cause of refusal to walk in a child. Pediatr Rheumatol. 2015;13:23.

    Article  Google Scholar 

  148. Fain O. Musculoskeletal manifestations of scurvy. Joint Bone Spine. 2005;72(2):124–8.

    Article  PubMed  Google Scholar 

  149. Weinstein M, Babyn P, Zlotkin S. An orange a day keeps the doctor away: scurvy in the year 2000. Pediatrics. 2001;108:E55.

    Article  CAS  PubMed  Google Scholar 

  150. Gaby A. Urticaria. Chapter 199. In: Gaby A, editor. Nutritional medicine. 2nd ed. Concord: Fritz Perlberg Publishing; 2017. p. 779–83.

    Google Scholar 

  151. De Spirt S, Stahl W, Tronnier H, Sies H, Bejot M, Maurette JM, Heinrich U. Intervention with flaxseed and borage oil supplements modulates skin condition in women. Br J Nutr. 2009;101(3):440–5.

    Article  CAS  PubMed  Google Scholar 

  152. Hong SH, Kwak JH, Paik JK, Chae JS, Lee JH. Association of polymorphisms in FADS gene with age-related changes in serum phospholipid polyunsaturated fatty acids and oxidative stress markers in middle-aged nonobese men. Clin Interv Aging. 2013;8:585–96.

    CAS  PubMed  PubMed Central  Google Scholar 

  153. Neukam KH, Hambidge KM. Zinc therapy of acrodermatitis enteropathica. N Engl J Med. 1975;292:879–82.

    Article  Google Scholar 

  154. Neukam K, De Spirt S, Stahl W, Bejot M, Maurette JM, Tronnier H, Heinrich U. Supplementation of flaxseed oil diminishes skin sensitivity and improves skin barrier function and condition. Skin Pharmacol Physiol. 2011;24(2):67–74. https://doi.org/10.1159/000321442.

    Article  CAS  PubMed  Google Scholar 

  155. Agero AL, Verallo-Rowell VM. A randomized double-blind controlled trial comparing extra virgin coconut oil with mineral oil as a moisturizer for mild to moderate xerosis. Dermatitis. 2004;15(3):109–16.

    Article  PubMed  Google Scholar 

  156. Krutmann J, Humbers P, editors. Nutrition for health skin. Strategies for clinical cosmetic practice. New York: Springer; 2011.

    Google Scholar 

  157. Pappas A, editor. Nutrition and skin: lessons for anti-aging, beauty and healthy skin. New York: Springer; 2011.

    Google Scholar 

  158. Davis D, Epp M, Riordan H. Changes in USDA food composition data for 43 garden crops, 1950 to 1999. J Am Coll Nutr. 2004;23(6):669–82.

    Article  CAS  PubMed  Google Scholar 

  159. Mayer AM. Historical changes in the mineral content of fruits and vegetables. Br Food J. 1997;99(6):207–11.

    Article  Google Scholar 

  160. Rushto DH. Nutritional factors and hair loss. Clin Exp Dermatol. 2002;27(5):396–404.

    Article  Google Scholar 

  161. Rawlings AV. Essential fatty acids and atopic dermatitis. Chapter 11. In: Pappas A, editor. Nutrition and skin: lessons for anti-aging, beauty and healthy skin. New York: Springer; 2011. p. 159–75.

    Chapter  Google Scholar 

  162. Schafer L, Kragballe K. Abnormal epidermal lipid metabolism in patients with atopic dermatitis. J Invest Dermatol. 1991;96:10–5.

    Article  CAS  PubMed  Google Scholar 

  163. Elewa RM, Zoubouli CC. Vitamin A and the skin. In: Pappas A, editor. Nutrition and skin. Lessons for anti-aging, beauty and healthy skin. New York: Springer; 2011. p. 7–24.

    Google Scholar 

  164. Lobo GP, Amengual J, Baus D, Shivdasani RA. Genetics and diet regulate vitamin A production via the homeobox transcription factor ISX. J Biol Chem. 2013;288(13):9017–27.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  165. Bikle DD. Vitamin D metabolism and function in the skin. Mol Cell Endocrinol. 2011;347(1–2):80–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  166. Kamradt J, Rafi L, Mitschele T, Meineke V, Gartner BC, Tilgen W, Holick MF, Reichrath J. Analysis of the Vitamin D system in cutaneous malignancies. Recent Results Cancer Res. 2003;164:259–69.

    Article  CAS  PubMed  Google Scholar 

  167. Wadhwa B, Relhan V, Goel K, Kochhar AM, Garg VK. Vitamin D and skin diseases: a review. Indian J Dermatol Venereol Leprol. 2015;81(4):344–55.

    Article  PubMed  Google Scholar 

  168. Hutchinson PE, Osborne JE, Lear JT, Bowers PW, Morris PN, Jones PW, et al. Vitamin receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma. Clin Cancer Res. 2000;6:498–504.

    CAS  PubMed  Google Scholar 

  169. Trémezaygues L, Reichrath J. From the bench to emerging new clinical concepts. Our present understanding of the importance of the vitamin D endocrine system (VDES) for skin cancer. Dermatoendocrinol. 2011;3:11–7. https://doi.org/10.4161/derm.3.1.14875.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  170. Kerns JC, Arundel C, Chawla LS. Thiamin deficiency in people with obesity. Adv Nutr. 2015;6:147–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  171. Larkin JR, Zhang F, Godfrey L, Motostvov G, Zehnder D, Rabbani N, Thornalley PJ. Glucose-induced down regulation of thiamine transporters in the kidney proximal tubular epithelium produces thiamine insufficiency in diabetes. PLoS One. 2012;7(12):e53175.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  172. Hammes HP, Du X, Edelstein D, Taguchi T, Matsumura T, Ju Q, Lin J, Bierhaus A, Nawroth P, Hannak D, Neumaier M, Bergfeld R, Giardino I, Brownlee M. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med. 2003;9(3):294–9.

    Article  CAS  PubMed  Google Scholar 

  173. Lin J, Alt A, Liersch J, Bretzel RG, Brownlee M. Benfotiamine inhibits intracellular formation of advanced glycation end products in vivo. Diabetes. 2000;49(Suppl 1):(A143) 583.

    Google Scholar 

  174. Pinto JT, Zempleni J. Riboflavin. Adv Nutr. 2016;7:973–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  175. Tanno O, Ota Y, Kitamura N, Katsube T, Inoue S. Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier. Br J Dermatol. 2000;143:524–31.

    Article  CAS  PubMed  Google Scholar 

  176. Pizzorno J. Symptoms by toxins. In: The toxin solution. New York, NY: Harper Collins; 2017. p. 236–7.

    Google Scholar 

  177. Yiasemides E, Sivapirabu G, Halliday GM, Park J, Damian DL. Oral nicotinamide protects against ultraviolet radiation induced immunosuppression in humans. Carcinogenesis. 2009;30:101–5.

    Article  CAS  PubMed  Google Scholar 

  178. Rossignol DA, Frye RE. Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism. Front Physiol. 2014;5(150):1–15.

    Google Scholar 

  179. Theoharides TC, Angelidou A, Alysandratos K-D, Zhang B, Asadi S, Francis K, Toniato E, Kalogeromitros D. Mast cell activation and autism. Biochim Biophys Acta. 2012;1822:34–41.

    Article  CAS  PubMed  Google Scholar 

  180. Knip M, Douek IF, Moore WP, et al. Safety of high-dose nicotinamide: a review. Diabetologia. 2000;43:1337–45.

    Article  CAS  PubMed  Google Scholar 

  181. Klatt KC, Caudill MA. Folate, choline, vitamin B12, vitamin B6 Ch. 22. In: Stipanuk MH, Caudill MA, editors. Biochemical, physiological and molecular aspects of human nutrition. 4th ed. St. Louis: Elsevier; 2019. p. 614–58.

    Google Scholar 

  182. Trumbo PR. Pantothenic acid. In: Shils ME, Shike M, Ross AC, et al., editors. Modern nutrition in health and disease. 10th ed. Baltimore: Lippincott Williams and Wilkins; 2006. p. 462–9.

    Google Scholar 

  183. Field H Jr, Green ME, Wilkinson CW Jr. Glossitis and cheilosis healed following the use of calcium pantothenate. Am J Dig Dis. 1945;12:246–50.

    Article  Google Scholar 

  184. Leung LH. Pantothenic acid deficiency as the pathogenesis of acne vulgaris. Med Hypotheses. 1995;44:490–2.

    Article  CAS  PubMed  Google Scholar 

  185. Goldman L. Intensive panthenol therapy of lupus erythematosus. J Invest Dermatol. 1950;15:291–3.

    Article  CAS  PubMed  Google Scholar 

  186. Bermudez Y, Cordova K, Williams JD. Folate nutrition in skin health and skin cancer prevention. In: Watson RR, Zibadi S, editors. Bioactive dietary factors and plant extracts in dermatology, nutrition and health. New York: Springer Science+Business Media; 2013. p. 229–56.

    Chapter  Google Scholar 

  187. Neyestani TR, Vitamin D. Skin cancer: meet sunshine halfway. In: Watson R, Zibadi S, editors. Bioactive dietary factors and plant extracts in dermatology. nutrition and health. Totowa: Humana Press; 2013. p. 257–68.

    Chapter  Google Scholar 

  188. Schallreuter KU, et al. Regulation of melanogenesis-controversies and new concepts. Exp Dermatol. 2008;17(5):395–404.

    Article  CAS  PubMed  Google Scholar 

  189. Bjorkegren K, Svardsudd K. Reported symptoms and clinical findings in relation to serum cobalamin, folate, methylmalonic acid and total homocysteine among elderly Swedes: a population-based study. J Intern Med. 2003;254(4):343–52.

    Article  CAS  PubMed  Google Scholar 

  190. Saini R, Badole SL, Zanwar AA. Vitamin C (L-Ascorbic Acid): antioxidant involved in skin care. Ch. 6. In: Watson RR, Zibadi S, editors. Bioactive dietary factors and plant extracts in dermatology. New York: Humana Press; 2013. p. 61–6.

    Chapter  Google Scholar 

  191. Kohlmeier M. Nutrigenetics: applying the science of personal nutrition. Chapter 4. In: How nutrients are affected by genetics. Waltham: Elsevier; 2013. p. 167.

    Google Scholar 

  192. Eck P, Erichsen HC, Taylor JG, Yeager M, Hughes AL, Levine M, et al. Comparison of the genomic structure and variation in the two human sodium-dependent vitamin C transporters, SLC23A1 and SLC23A2. Hum Genet. 2004;115(4):285–94.

    Article  CAS  PubMed  Google Scholar 

  193. Savini I, Rossi A, Pierro C, Avigliano L, Catani MV. SVCT1 and SVCT2: key proteins for vitamin C uptake. Amino Acids. 2008;34(3):347–55.

    Article  CAS  PubMed  Google Scholar 

  194. Centilli M, Legacy M, Legacy M, Seiger E. Acrodermatitis enteropathica. Consultant. 2014;54(7):543–5.

    Google Scholar 

  195. Gehrig KA, Dinulos JG. Acrodermatitis due to nutritional deficiency. Curr Opin Pediatr. 2010;22(1):107–12.

    Article  PubMed  Google Scholar 

  196. Winkler P. Minerals and the skin. Chapter 7. In: Pappas A, editor. Nutrition and skin. Lessons for anti-aging, beauty and healthy skin. New York: Springer; 2011. p. 91–109.

    Google Scholar 

  197. Bleasel NR, Stapleton KM, Lee MS, Sullivan J. Vitamin A deficiency phrynoderma: due to malabsorption and inadequate diet. J Am Acad Dermatol. 1999;41:322–4.

    Article  CAS  PubMed  Google Scholar 

  198. Primavesi L, Piantanida M, Pravettoni V. Mediterranean diet and skin health. In: Watson R, Zibadi S, editors. Bioactive dietary factors and plant extracts in dermatology. New York: Humana Press; 2013.

    Google Scholar 

  199. Kastorini CM, Milionis HJ, Esposito K, Giugliano D, Goudevenos JA, Panagiotakos DB. The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals. J Am Coll Cardiol. 2011;57(11):1299–313.

    Article  CAS  PubMed  Google Scholar 

  200. Hardy TM, Tollefsbol TO. Epigenetic diet: impact on the epigenome and cancer. Epigenomics. 2011;3(4):503–18.

    Article  CAS  PubMed  Google Scholar 

  201. Chafen JJ, et al. Diagnosing and managing common food allergies: a systematic review. JAMA. 2010;303(18):1848–56.

    Article  PubMed  Google Scholar 

  202. Lucendo AJ, Arias A, Gonzalez-Cervera J, Yague-Compadra JL, Guagnozzi D, Angueira T, Jimenez-Contreras S, Gonzalez-Castillo S, Rodriguez-Domingez B, DeRezende LC, Tenias JM. Empiric 6-food elimination diet induced and maintained prolonged remission in patients with adult eosinophilic esophagitis: a prospective study on the food cause of the disease. J Allergy Clin Immunol. 2013;131(3):797–804.

    Article  PubMed  Google Scholar 

  203. Alonso PE, Rioja LF. Solanidine and tomatidine trigger scar pruritus. Burns. 2016;42(3):535–40.

    Article  PubMed  Google Scholar 

  204. Guida B, De Martino CD, De Martino SD, Tritto G, Patella V, Trio R, D’Agostino C, Pecoraro P, D’Agostino L. Histamine plasma levels and elimination diet in chronic idiopathic urticaria. Eur J Clin Nutr. 2000;54(2):155–8.

    Article  CAS  PubMed  Google Scholar 

  205. Noh G, Jin H, Lee J, Noh J, Lee WM, Lee S. Eosinophilia as a predictor of food allergy in atopic dermatitis. Allergy Asthma Proc. 2010;31(2):e18–24.

    Article  CAS  PubMed  Google Scholar 

  206. Dhar S, Malakar R, Banerjee R, Chakraborty S, Chakraborty J, Mukherjee S. An uncontrolled open pilot study to assess the role of dietary eliminations in reducing the severity of atopic dermatitis in infants and children. Indian J Dermatol. 2009;54(2):183–5.

    Article  PubMed  PubMed Central  Google Scholar 

  207. Janssens V, Morren M, Dooms-Goossens A, et al. Protein contact dermatitis: myth or reality? Br J Dermatol. 1995;132:1–6.

    Article  CAS  PubMed  Google Scholar 

  208. Sander I. Acanthosis nigricans. www.uptodate.com. Wolters Kluwer; 2017. Accessed 5-1-2017.

  209. Ozdemir O, Zanwar AA. The role of probiotics in atopic dermatitis and skin allergy reactions: prevention and therapy. Chapter 4. In: Watson RR, Zibadi S, editors. Bioactive dietary factors and plant extracts in dermatology. Nutrition and health. New York: Springer science+Business Media; 2013. p. 493–529.

    Chapter  Google Scholar 

  210. Pohjavuori E, Vilanen M, Korpela R, Kuitunen M, Sarnesto A, Vaarala O, Savilahti E. Induction of inflammation as a possible mechanism of probiotic effect in atopic eczema-dermatitis syndrome. J Allergy Clin Immunol. 2005;115:1254–9.

    Article  PubMed  Google Scholar 

  211. Viljanen M, Pohjavuori E, Haahtela T, Korpela R, Kuitunen M, Sarnesto A, Vaarala O, Savilahti E. Induction of inflammation as a possible mechanism of probiotic effect in atopic eczema-dermatitis syndrome. J Allergy Clin Immunol. 2005;115:1254–9.

    Article  CAS  PubMed  Google Scholar 

  212. Gueniche A, Benyacoub J, Buetler T, Smola H, Blum S. Supplementation with oral probiotic bacteria maintains cutaneous immune homeostasis after UV exposure. Eur J Dermatol. 2006;16:511–7.

    PubMed  Google Scholar 

  213. Melnik BC. Linking diet to acne metabolomics, inflammation and comedogenesis: an update. Clin Cosmet Investig Dermatol. 2015;8:371–88.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  214. Teitelbaum JE. Nutrient deficiencies and inflammatory bowel disease. UptoDate. Accessed 4 Aug 2017.

    Google Scholar 

  215. Filippi J, Al-Jaouni R, Wiroth JB, et al. Nutritional deficiencies in patients with Crohn’s disease in remission. Inflamm Bowel Dis. 2006;12:185.

    Article  PubMed  Google Scholar 

  216. Abu-Qurshin R, Naschitz JE, Zuckermann E, et al. Crohn’s disease associated with pellagra and increased excretion of 5-hydroxyindoleacetic acid. Am J Med Sci. 1997;313:111.

    CAS  PubMed  Google Scholar 

  217. Pollack S, Enat R, Haim S, et al. Pellagra as the presenting manifestation of Crohn’s disease. Gastroenterology. 1982;82:948.

    Article  CAS  PubMed  Google Scholar 

  218. Kulnigg S, Gasche C. Systematic review: managing anaemia in Crohn’s disease. Aliment Pharmacol Ther. 2006;24:1507.

    Article  CAS  PubMed  Google Scholar 

  219. Vagianos K, Bector S, McConnell J, Bernstein CN. Nutrition assessment of patients with inflammatory bowel disease. JPEN J Parenter Enteral Nutr. 2007;31:311.

    Article  CAS  PubMed  Google Scholar 

  220. Seidman E, LeLeiko N, Ament M, et al. Nutritional issues in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 1991;12:424.

    Article  CAS  PubMed  Google Scholar 

  221. Headstrom PD, Rulyak SJ, Lee SD. Prevalence of and risk factors for vitamin B(12) deficiency in patients with Crohn’s disease. Inflamm Bowel Dis. 2008;14:217.

    Article  PubMed  Google Scholar 

  222. Main AN, Mills PR, Russell RI, et al. Vitamin A deficiency in Crohn’s disease. Gut. 1983;24:1169.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  223. Driscoll RH Jr, Meredith SC, Sitrin M, Rosenberg IH. Vitamin D deficiency and bone disease in patients with Crohn’s disease. Gastroenterology. 1982;83:1252.

    Article  PubMed  Google Scholar 

  224. Pappa HM, Grand RJ, Gordon CM. Report on the vitamin D status of adult and pediatric patients with inflammatory bowel disease and its significance for bone health and disease. Inflamm Bowel Dis. 2006;12:1162.

    Article  PubMed  Google Scholar 

  225. Pappa HM, Langereis EJ, Grand RJ, Gordon CM. Prevalence and risk factors for hypovitaminosis D in young patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2011;53:361.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  226. Sentongo TA, Semaeo EJ, Stettler N, et al. Vitamin D status in children, adolescents, and young adults with Crohn disease. Am J Clin Nutr. 2002;76:1077.

    Article  CAS  PubMed  Google Scholar 

  227. Prosnitz AR, Leonard MB, Shults J, et al. Changes in vitamin D and parathyroid hormone metabolism in incident pediatric Crohn’s disease. Inflamm Bowel Dis. 2013;19:45.

    Article  PubMed  Google Scholar 

  228. Vogelsang H, Schöfl R, Tillinger W, et al. 25-hydroxyvitamin D absorption in patients with Crohn’s disease and with pancreatic insufficiency. Wien Klin Wochenschr. 1997;109:678.

    CAS  PubMed  Google Scholar 

  229. Gisbert JP, Gomollón F. Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease. Am J Gastroenterol. 2008;103:1299.

    Article  PubMed  Google Scholar 

  230. Cronin CC, Shanahan F. Anemia in patients with chronic inflammatory bowel disease. Am J Gastroenterol. 2001;96:2296.

    Article  CAS  PubMed  Google Scholar 

  231. Wells CW, Lewis S, Barton JR, Corbett S. Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Inflamm Bowel Dis. 2006;12:123.

    Article  PubMed  Google Scholar 

  232. Alkhouri RH, Hashmi H, Baker RD, et al. Vitamin and mineral status in patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2013;56:89.

    Article  CAS  PubMed  Google Scholar 

  233. McClain C, Soutor C, Zieve L. Zinc deficiency: a complication of Crohn’s disease. Gastroenterology. 1980;78:272.

    Article  CAS  PubMed  Google Scholar 

  234. Sturniolo GC, Di Leo V, Ferronato A, et al. Zinc supplementation tightens “leaky gut” in Crohn’s disease. Inflamm Bowel Dis. 2001;7:94.

    Article  CAS  PubMed  Google Scholar 

  235. Institute of Medicine, Food and Nutrition Board. Dietary reference intakes for calcium and vitamin D. Washington DC: National Academy Press; 2011. https://www.nap.edu/search/?term=13050.

    Google Scholar 

  236. Rannem T, Ladefoged K, Hylander E, et al. Selenium status in patients with Crohn’s disease. Am J Clin Nutr. 1992;56:933.

    Article  CAS  PubMed  Google Scholar 

  237. Kuroki F, Matsumoto T, Iida M. Selenium is depleted in Crohn’s disease on enteral nutrition. Dig Dis. 2003;21:266.

    Article  PubMed  Google Scholar 

  238. Johtatsu T, Andoh A, Kurihara M, et al. Serum concentrations of trace elements in patients with Crohn’s disease receiving enteral nutrition. J Clin Biochem Nutr. 2007;41:197.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  239. Goldschmid S, Graham M. Trace element deficiencies in inflammatory bowel disease. Gastroenterol Clin North Am. 1989;18:579.

    CAS  PubMed  Google Scholar 

  240. Spiegel JE, Willenbucher RF. Rapid development of severe copper deficiency in a patient with Crohn’s disease receiving parenteral nutrition. JPEN J Parenter Enteral Nutr. 1999;23:169.

    Article  CAS  PubMed  Google Scholar 

  241. Galland L. Magnesium and inflammatory bowel disease. Magnesium. 1988;7:78.

    CAS  PubMed  Google Scholar 

  242. Habtezion A, Silverberg MS, Parkes R, et al. Risk factors for low bone density in Crohn’s disease. Inflamm Bowel Dis. 2002;8:87.

    Article  PubMed  Google Scholar 

  243. Park RH, Galloway A, Shenkin A, et al. Magnesium deficiency in patients on home enteral nutrition. Clin Nutr. 1990;9:147.

    Article  CAS  PubMed  Google Scholar 

  244. Huang BL, Chandra S, Shih DQ. Skin manifestations of inflammatory bowel disease. Front Physiol. 2012;3:13.

    PubMed  PubMed Central  Google Scholar 

  245. Das DK, Vasanthi H. Resveratrol in dermal health. Chapter 18. In: Watson RR, Zibadi S, editors. Bioactive dietary factors and plant extracts in dermatology. Nutrition and health. New York: Springer Science+Business Media; 2013. p. 177–87.

    Chapter  Google Scholar 

  246. Fabbrocini G, De Vita V, Monfrecola A, De Padova MP, Brazzini B, Teixeira F, Chu A. Percutaneous collagen induction: an effective and safe treatment for post-acne scarring in different skin phototypes. J Dermatolog Treat. 2014;25(2):147–52. https://doi.org/10.3109/09546634.2012.742949.

    Article  CAS  PubMed  Google Scholar 

  247. Aggarwal BB, Shishodia S. Suppression of nuclear factor-Kappa B activation pathway by spice-derived phytochemicals: reasoning for seasoning. Ann N Y Acad Sci. 2004;1040:434–41.

    Article  CAS  Google Scholar 

Key Textbook Resources for Further Reading

  • Gaby A, editor. Nutritional medicine. 2nd ed. Concord: Fritz Perlberg Publishing; 2017.

    Google Scholar 

  • Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffel DJ, Wolff K, editors. Fitzpatrick’s dermatology in general medicine. 8th ed. New York: McGraw Hill; 2012.

    Google Scholar 

  • Habif TP, editor. Clinical dermatology. 5th ed. Edinburgh: Mosby Elsevier; 2010.

    Google Scholar 

  • Krutmann J, Humbers P, editors. Nutrition for healthy skin. Strategies for clinical cosmetic practice. New York: Springer; 2011.

    Google Scholar 

  • Pappas A, editor. Nutrition and skin: lessons for anti-aging, beauty and healthy skin. New York: Springer; 2011.

    Google Scholar 

  • Watson RR, Zibadi S, editors. Bioactive dietary factors and plant extracts in dermatology. Nutrition and health. New York: Springer Science+Business Media, Humana Press; 2013.

    Google Scholar 

  • Wolff K, Johnson RA, Saavedra AP, editors. Fitzpatrick’s color atlas and synopsis of clinical dermatology 7th edition. New York: McGraw-Hill Companies; 2013.

    Google Scholar 

Internet Resources

Download references

Author information

Authors and Affiliations

  1. Ashland Comprehensive Family Medicine-Stone Medical, Ashland, OR, USA

    P. Michael Stone

  2. Institute for Functional Medicine, Federal Way, WA, USA

    P. Michael Stone

  3. Asante Ashland Community Hospital, Ashland, OR, USA

    P. Michael Stone

Authors
  1. P. Michael Stone
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. Michael Stone .

Editor information

Editors and Affiliations

  1. Noland Nutrition, Burbank, CA, USA

    Diana Noland

  2. Professor Emeritus, School of Medicine, University of Kansas Health System, Kansas City, KS, USA

    Jeanne A. Drisko

  3. Department of Dietetics & Nutrition, University of Kansas Medical Center, Kansas City, KS, USA

    Leigh Wagner

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Stone, P.M. (2020). The Skin, Selected Dermatologic Conditions, and Medical Nutrition Therapy. In: Noland, D., Drisko, J., Wagner, L. (eds) Integrative and Functional Medical Nutrition Therapy. Humana, Cham. https://doi.org/10.1007/978-3-030-30730-1_52

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-30730-1_52

  • Published:

  • Publisher Name: Humana, Cham

  • Print ISBN: 978-3-030-30729-5

  • Online ISBN: 978-3-030-30730-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation